363 related articles for article (PubMed ID: 27619971)
1. The role of microRNAs in intrahepatic cholangiocarcinoma.
Li Z; Shen J; Chan MT; Wu WK
J Cell Mol Med; 2017 Jan; 21(1):177-184. PubMed ID: 27619971
[TBL] [Abstract][Full Text] [Related]
2. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
Zhang MY; Li SH; Huang GL; Lin GH; Shuang ZY; Lao XM; Xu L; Lin XJ; Wang HY; Li SP
BMC Cancer; 2015 Feb; 15():64. PubMed ID: 25880914
[TBL] [Abstract][Full Text] [Related]
5. The Role of microRNAs in Cholangiocarcinoma.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299246
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C.
Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H
Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768
[TBL] [Abstract][Full Text] [Related]
7. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
Kawahigashi Y; Mishima T; Mizuguchi Y; Arima Y; Yokomuro S; Kanda T; Ishibashi O; Yoshida H; Tajiri T; Takizawa T
J Nippon Med Sch; 2009 Aug; 76(4):188-97. PubMed ID: 19755794
[TBL] [Abstract][Full Text] [Related]
9. Integration analysis of miRNA-mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma.
Liu L; Shi Y; Zhang P; Zhang X
Sci Rep; 2023 May; 13(1):8362. PubMed ID: 37225858
[TBL] [Abstract][Full Text] [Related]
10. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
[TBL] [Abstract][Full Text] [Related]
12. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
14. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
[TBL] [Abstract][Full Text] [Related]
15. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
17. Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini.
Plieskatt JL; Rinaldi G; Feng Y; Peng J; Yonglitthipagon P; Easley S; Laha T; Pairojkul C; Bhudhisawasdi V; Sripa B; Brindley PJ; Mulvenna JP; Bethony JM
J Hepatol; 2014 Oct; 61(4):850-8. PubMed ID: 25017828
[TBL] [Abstract][Full Text] [Related]
18. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
[TBL] [Abstract][Full Text] [Related]
19. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma.
Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC
Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888
[TBL] [Abstract][Full Text] [Related]
20. CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma.
Xu W; Yu S; Xiong J; Long J; Zheng Y; Sang X
Aging (Albany NY); 2020 Jan; 12(2):1047-1086. PubMed ID: 31956102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
